Journal of the Neurological Sciences
Volume 222, Issue 1 , Pages 21-27 , 15 July 2004

Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis

  • Suhali Al-Shammri

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +965-5319596; fax: +965-5338907.
    • Department of Medicine, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait
    • ,
  • Parvez Rawoot

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait
    • ,
  • Fawaz Azizieh

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait
    • ,
  • Amr AbuQoora

      Affiliations

    • Mubarak Al-Kabir Hospital, Kuwait
    • ,
  • Magdy Hanna

      Affiliations

    • Mubarak Al-Kabir Hospital, Kuwait
    • ,
  • T.R Saminathan

      Affiliations

    • Mubarak Al-Kabir Hospital, Kuwait
    • ,
  • Raj Raghupathy

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait

Received 26 August 2003 ,Revised 23 February 2004 ,Accepted 26 March 2004.

References 

  1. Silberberg D. Editorial: millennium reflections. Multiple Sclerosis. 2001;7:1–3
  2. Windhagen A, et al.  Role of Th1 and Th2 cells in neurologic disorders. In:  Romagnani S editors. Th1 and Th2 cells in health and disease. Basel: Karger; 1996;p. 171–186
  3. Cuzner ML, Hayes GM, Necombe J, Woodroofe MN. The nature of inflammatory components during demyelination in multiple sclerosis. J. Neuroimmunol. 1988;20:203–209
  4. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J. A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis. J. Exp. Med. 2001;194:669–676
  5. Ochi H, Wu XM, Osoegawa M, Horiuchi I, Minohara M, Murai H, et al.  Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis. J. Neuroimmunol. 2001;119:297–305
  6. Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudick RA. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch. Neurol. 1990;47:738–742
  7. Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis—a 3-year prospective study. J. Neurol. 1994;241:228–233
  8. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain. 1995;118:253–261
  9. Damek DM, Shuster EA. Pregnancy and multiple sclerosis. Mayo Clin. Proc. 1997;72:977–989
  10. Confavreux C, et al.  Rate of pregnancy-related relapse in multiple sclerosis. N. Engl. J. Med. 1998;339:285–291
  11. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunol. Today. 1993;14:353–356
  12. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin. Immunol. 2001;13:219–227
  13. Birk K, Rudick R. Pregnancy and multiple sclerosis. Arch. Neurol. 1986;43:719–725
  14. Mosmann TR, Sad S. The expanding universe of T-cell subsets. Immunol. Today. 1996;7:138–146
  15. Coffman RL, Romagnani S. Redirecting Th1 and Th2 subsets. Berlin: Springer-Verlag; 1999;
  16. Hintzen RQ, Polman CH. Th-cell modulation in multiple sclerosis. Immunol. Today. 1997;18:507–509
  17. Rohowsky-Kochan C, Molinaro D, Cook SD. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis. Mult. Scler. 2000;6:69–77
  18. Clerici M, Saresella M, Trabattoni D, Speciale L, Fossati S, Ruzzante S, et al.  Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J. Neruoimmunol. 2001;121:88–101
  19. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983;13:227–231
  20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;1444–1452
  21. Correale J, Gilmore W, McMillan M, Li S, McCarthy K, Le T, et al.  Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol. 1995;154:2959–2968
  22. Benvenuto R, Paroli M, Buttinelli C, Franco A, Barnaba V, Fieschi C, et al.  Tumor necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis. Clin. Exp. Immunol. 1991;84:97–102
  23. Neuhaus O, Farina C, Yassouridis A, Wiendl H, Then Borgh F, Dose T, et al.  Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper-1 to T helper 2 cells. Proc. Natl. Acad. Sci. 2000;97:7452–7457
  24. Piccinni MP, Giudizi M, Biagotti R, et al.  Progesterone favors the development of human T helper cells producing Th2 type cytokines and promotes IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 1995;155:203–217
  25. Correale J, Arias M, Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid-specific CD4+ T cell clones from multiple sclerosis patients and normal control subjects. J. Immunol. 1998;161:3365–3374
  26. Sicotte NL, Liva SM, Klutch R, et al.  Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 2002;421–428

PII: S0022-510X(04)00096-6

doi: 10.1016/j.jns.2004.03.027

Journal of the Neurological Sciences
Volume 222, Issue 1 , Pages 21-27 , 15 July 2004

Article Tools

* Image Usage & Resolution